Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MYNZ is expected to report earnings to fall 24.53% to -200 cents per share on November 13
Q3'25
Est.
$-2.00
Q2'25
Missed
by $0.25
Q4'24
Missed
by $1.31
Q3'24
Missed
by $4.27
Q2'24
Missed
by $19.45
The last earnings report on September 03 showed earnings per share of -265 cents, missing the estimate of -240 cents. With 691.40K shares outstanding, the current market capitalization sits at 7.42M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MYNZ showed earnings on September 03, 2025. You can read more about the earnings report here.